Clinical Coagulation, Malmö
1 – 10 of 650
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Thrombotic risk determined by ABO, F8, and VWF variants in a population-based cohort study
(
- Contribution to journal › Article
-
Mark
Fibrinogen genotypes and their impact on recurrence of venous thromboembolism and family history : A prospective population-based study
2025) In British Journal of Haematology(
- Contribution to journal › Article
-
Mark
Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Haemate P) in von Willebrand Disease : A Systematic Review and Pharmacovigilance Update
(
- Contribution to journal › Article
-
Mark
Dronedarone provides effective early rhythm control : post-hoc analysis of the ATHENA trial using EAST-AFNET 4 criteria
(
- Contribution to journal › Article
-
Mark
Real-world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Vägar till svensk legitimation för läkare utbildade i tredje land
(
- Contribution to journal › Article
-
Mark
Thrombotic risk determined by CREB3L1 variants in a population-based cohort study : linkage disequilibrium with prothrombin mutation
(
- Contribution to journal › Letter
- 2024
-
Mark
Etranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B) : 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial
(
- Contribution to journal › Article
-
Mark
SERPINH1 variants and thrombotic risk among middle-aged and older adults : a population-based cohort study
(
- Contribution to journal › Letter
-
Mark
Low bleeding rates after intramuscular Covid-19 vaccination in patients with haemophilia and von Willebrand disease : Outcome data from the Swedish haemophilia registry
(
- Contribution to journal › Debate/Note/Editorial